A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

Clinical trial NCT02438007 · TERMINATED

Trial details

NCT number: NCT02438007
Sponsor: LTN PHARMACEUTICALS, INC.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2015-06-01
Primary completion: 2016-07-01
Enrollment: 953

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.